A clinical-stage oncology company with a potentially ground-breaking technology requested Kineticos to help determine which tumor type(s) had the greatest potential to demonstrate patient benefit.  The sponsor was considering 2 tumor types internally and requested that Kineticos conduct a Commercial Assessment to help understand the patient journey, unmet need, and commercial potential of Melanoma as it related to their technology.


After thoroughly examining data provided by the sponsor, Kineticos performed an in-depth analysis of the Melanoma market and produced a comprehensive disease/treatment overview and competitive landscape analysis (including marketed therapies, standard of care, and clinical programs). Kineticos also segmented the potential customers to determine where the patient handoffs occurred and what types of decisions were made by medical oncologist vs. surgical oncologist during the patient journey.


Kineticos was able to provide the sponsor with an extremely nuanced view of the complex market, data-driven recommendations for targeting specific patient segments, and a view of the commercial opportunity in the Melanoma space. Kineticos presented the commercial assessment to the executive management team and stimulated healthy debate regarding their clinical development plan.  Ultimately, the assessment validated the sponsor’s original view on Melanoma and decisions were able to be made with confidence and with the support of facts and data.